Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983538 · ClinicalTrials.gov registry record
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
A clinical trial, sponsored by New Mexico Cancer Research Alliance.
- Completed
- Registry status
- 10
- Enrollment target
NCT03983538 is a clinical trial that has completed, run by New Mexico Cancer Research Alliance. The registered enrollment target is 10 participants.
The verdict
NCT03983538 has completed, sponsored by New Mexico Cancer Research Alliance.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a feasibility study evaluating the use of a mathematical model to predict response to standard neoadjuvant anthracycline / taxane based chemotherapy in patients with breast cancer.
Interventions
- OTHER Mathematical modeling to predict response to chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-06-02 |
| Est. Completion | 2018-01-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983538
The ClinicalTrials.gov registry entry for NCT03983538 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New Mexico Cancer Research Alliance, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mathematical modeling to predict response to chemotherapy is the first listed.
NCT03983538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983538 about?
NCT03983538 is a clinical study titled "Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer". This is a feasibility study evaluating the use of a mathematical model to predict response to standard neoadjuvant anthracycline / taxane based chemotherapy in patients with breast cancer.
What is the current status of trial NCT03983538?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2015-06-02. Estimated completion is 2018-01-28.
What interventions are being tested in trial NCT03983538?
The interventions under investigation include: Mathematical modeling to predict response to chemotherapy (OTHER).
Who is sponsoring clinical trial NCT03983538?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.